Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Marinus (MRNS)
NASDAQ:MRNS
Marinus (MRNS) Stock Price & Analysis
930 Followers
MRNS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.47 - $10.94
Previous Close$6.79
Volume412.54K
Average Volume (3M)423.77K
Market Cap
$337.23M
Enterprise Value$204.59M
Total Cash (Recent Filing)$240.55M
Total Debt (Recent Filing)$103.87M
Price to Earnings (P/E)-14.8
Beta0.85
Next Earnings
May 03, 2023EPS Estimate
-$0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding49,617,697
10 Day Avg. Volume482,765
30 Day Avg. Volume423,774
Standard Deviation0.26
R-Squared0.07
Alpha0.00211
Financial Highlights & Ratios
Price to Book (P/B)4.66
Price to Sales (P/S)19.83
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.03
Enterprise Value/Gross Profit8.14
Enterprise Value/Ebitda-38.33
Forecast
1Y Price Target
$22.63Price Target Upside233.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Marinus News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MRNS FAQ
What was Marinus’s price range in the past 12 months?
Marinus lowest stock price was $3.46 and its highest was $10.94 in the past 12 months.
What is Marinus’s market cap?
Currently, no data Available
When is Marinus’s upcoming earnings report date?
Marinus’s upcoming earnings report date is May 03, 2023 which is in 44 days.
How were Marinus’s earnings last quarter?
Marinus released its earnings results on Mar 07, 2023. The company reported -$0.76 earnings per share for the quarter, missing the consensus estimate of -$0.62 by -$0.14.
Is Marinus overvalued?
According to Wall Street analysts Marinus’s price is currently Undervalued.
Does Marinus pay dividends?
Marinus does not currently pay dividends.
What is Marinus’s EPS estimate?
Marinus’s EPS estimate is -$0.73.
How many shares outstanding does Marinus have?
Marinus has 49,665,115 shares outstanding.
What happened to Marinus’s price movement after its last earnings report?
Marinus reported an EPS of -$0.76 in its last earnings report, missing expectations of -$0.62. Following the earnings report the stock price went up 5.398%.
Which hedge fund is a major shareholder of Marinus?
Among the largest hedge funds holding Marinus’s share is Woodline Partners LP. It holds Marinus’s shares valued at 6M.
---
Marinus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.63 (233.28% Upside)
$22.63 (233.28% Upside)
Hedge Fund Trend
Increased
By 203.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 6.6%
Last 30 Days ▲ 6.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.95%
12-Months-Change
Fundamentals
Return on Equity
-23.38%
Trailing 12-Months
Asset Growth
89.65%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Marinus
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.
---
Rain Therapeutics
―
scPharmaceuticals
―
Theseus Pharmaceuticals
―
Terns Pharmaceuticals
―
---